Cohort Studymoderate evidence
Real-World Experience With the Extravascular Implantable Cardioverter Defibrillator Through 1 Year: The Enlighten Post Approval Registry Study.
Circulation·September 22, 2026·PMID 42770223
Why it mattersReal-world data on the EV-ICD are limited, and this registry confirms that the device performs similarly outside clinical trials, with acceptable complication rates and reliable therapy delivery. The high shock success and meaningful ATP efficacy support its use as an alternative to transvenous ICDs, particularly for patients at risk of lead-related complications.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled